
Stearoylethanolamide
CAS No. 111-57-9
Stearoylethanolamide( —— )
Catalog No. M33236 CAS No. 111-57-9
Stearoylethanolamide(N-(2-Hydroxyethyl)octadecanamide) is a cannabinoid compound present in the brains of humans, rats, and mice with pro-apoptotic activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 38 | In Stock |
![]() ![]() |
10MG | 61 | In Stock |
![]() ![]() |
25MG | 98 | In Stock |
![]() ![]() |
50MG | 144 | In Stock |
![]() ![]() |
100MG | 215 | In Stock |
![]() ![]() |
200MG | 320 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameStearoylethanolamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionStearoylethanolamide(N-(2-Hydroxyethyl)octadecanamide) is a cannabinoid compound present in the brains of humans, rats, and mice with pro-apoptotic activity.
-
DescriptionStearoylethanolamide is an endocannabinoid-like compound with pro-apoptotic activity.
-
In VitroStearoylethanolamide (SEA) is present in human, rat and mouse brain in amounts comparable with those of the endocannabinoid anandamide (arachidonoylethanolamide; AEA). Stearoylethanolamide is an endocannabinoid-like compound with pro-apoptotic activity, which is regulated by NO in a way opposite to that reported for AEA.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number111-57-9
-
Formula Weight327.55
-
Molecular FormulaC20H41NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (101.76 mM; Ultrasonic (<60°C)
-
SMILESCCCCCCCCCCCCCCCCCC(=O)NCCO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Maccarrone M, et al. Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. Biochem J. 2002 Aug 15;366(Pt 1):137-44.?
molnova catalog



related products
-
D609
D609 (Tricyclodecan-9-yl-Xanthogenate) has a wide range of biological activities including antioxidant, antiapoptotic, anticholinergic, antitumor, anti-inflammatory, antiviral, antiproliferative, and neuroprotective activities.
-
Etalocib
Etalocib is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase.
-
Tebufenozide
Tebufenozide is a novel nonsteroidal ecdysone agonist.